Sun Pharmaceutical (SUNPHARMA) — Financial Results

Sun Pharmaceutical Industries Limited reported a 69.9% year-on-year increase in net profit to ₹87.22 crores for the quarter ended December 31, 2024, driven by strong performance in its specialty and generic segments. The company announced it will release third-quarter results on January 31, 2025, followed by an earnings call at 6:30 pm IST, with pre-registration required to avoid delays. Forward-looking statements in the filing caution that actual results may differ materially due to market conditions and operational risks.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this financial results affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 17 January 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 17 January 2025

RELIANCE Reliance Industries Limited Financial Results RELIANCE Reliance Industries Limited Announcement SBILIFE SBI Life Insurance Company Limited Financial Results SBILIFE SBI Life Insurance Company Limited Financial Results SBILIFE SBI Life Insurance Company Limited Financial Results TATASTEEL Tata Steel Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.